Eric Mosbrooker insider trades

Open-market stock purchases and sales by Eric Mosbrooker, Chief Commercial Officer at Avidity Biosciences, Inc, from SEC Form 4 filings since Nov 1, 2017.

Recent trades

DateStockTradeValue
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.6M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.6M
Dec 17, 2025RNA Avidity Biosciences, IncSold (not open market)$821K
Dec 17, 2025RNA Avidity Biosciences, IncBought (not open market)—
Dec 17, 2025RNA Avidity Biosciences, IncSold (not open market)$2.6M
Oct 3, 2025RNA Avidity Biosciences, IncSold$298K
Oct 3, 2025RNA Avidity Biosciences, IncBought (not open market)—

Companies traded

  • RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026
  • RNA Avidity Biosciences, Inc: 4 sales, last Dec 17, 2025
  • BOLD Audentes Therapeutics, Inc: other filings, last Jan 15, 2020
  • HZNP Horizon Pharma plc: other filings, last Nov 1, 2017

Get free alerts when Eric Mosbrooker files a new trade →